CTCBIO Inc (060590) — Capital Reinvestment Ratio
CTCBIO Inc (060590) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩5.64 Billion) in capital expenditures (₩212.02 Million). See debt-free asset ratio of CTCBIO Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CTCBIO Inc Capital Reinvestment Ratio (2013–2024)
This chart tracks CTCBIO Inc's Capital Reinvestment Ratio across 10 annual periods. Check how aggressively does CTCBIO Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for CTCBIO Inc (2013–2024)
Year-by-year Capital Reinvestment Ratio for CTCBIO Inc from 2013 to 2024. For live market cap and broader valuation context, see 060590 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩4.50 Billion | ₩2.14 Billion | ▲ +107.4% |
| 2023 | 0.23x | ₩8.22 Billion | ₩1.88 Billion | ▲ +31.8% |
| 2022 | 0.17x | ₩18.22 Billion | ₩3.17 Billion | ▼ -32.8% |
| 2021 | 0.26x | ₩6.46 Billion | ₩1.67 Billion | ▼ -93.1% |
| 2020 | 3.77x | ₩510.09 Million | ₩1.92 Billion | ▲ +185.2% |
| 2019 | 1.32x | ₩1.68 Billion | ₩2.22 Billion | ▼ -90.0% |
| 2017 | 13.22x | ₩295.30 Million | ₩3.90 Billion | ▲ +573.9% |
| 2016 | 1.96x | ₩6.86 Billion | ₩13.46 Billion | ▼ -88.1% |
| 2015 | 16.50x | ₩1.44 Billion | ₩23.71 Billion | ▲ +647.6% |
| 2013 | 2.21x | ₩2.74 Billion | ₩6.05 Billion | — |